Medical  Explorer

Custom Search

Drugs A to Z  :  A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  R  S  T  U  V  W  X  Y  Z
Medicinal Ingredients : A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z

Beauty Products : A  B  C  D  E  F  G  I  M  N  O  P  R  S  T  V

Aging      Allergies     Alzheimer's      Arthritis    Asthma      Bacteria   new Cancer    Chickenpox     Colds     Constipation      Diabetes      Epilepsy     Fatigue     Fever     Genetics       Haemorrhoids       newHeadaches      Hepatitis    Immunity      Infection      Insomnia       Leprosy       Menopause      Obesity      Osteoporosis     Other Diseases    Pain      PMS     Parasites     Sinusitis     newStroke     Toxicology    Urology




Arthritis medications
Acupuncture
Alcohol
Patients
newGeneral Health
Medicinal food
Chinese medicine
Nutrients
Smoking
Vitamins
OTC Drugs
Health Products
Therapy
Symptom
Parasitology
 
 

Postinor-2
 

ACTIVE SUBSTANCE
0.75mg levonorgestrel in each tablet.
Other ingredients: silica colloidal anhydrous, magnesium stearate, potato starch, talc, maize starch, lactose monohydrate.

ACTION
Levonorgestrel is a progestogen inhibiting the implantation of the ovum into the endometrium, stimulating the motility of the oviduct and increasing the viscosity of the cervical mucus.


When taken in the middle of the menstrual cycle, the preparation may inhibit ovulation.

INDICATION
Postinor-2 tablet is an emergency contraceptive preparation that can prevent conception if it is taken within 72 hours following unprotected intercourse.


The administration of Postinor-2 as an emergency contraceptive is recommended in the following cases
if no contraceptive measure of any kind was taken during intercourse,

if the applied contraceptive measure cannot be considered reliable, i.e.:

  - tear or slip or inappropriate use of condom,
  - disposition or tear or premature removal of diaphragm or pessary,

  - unsuccessfully interrupted coitus,
  - erroneous calculation of fertile days in case of periodic abstinence,

  - in case of IUD loss or removal,
  - omitting the ingestion of 3 or more hormonal contraceptive tablets to be taken regularly,

rape.

CONTRAINDICATIONS
Except for existing pregnancy, there are no other absolute medical contraindications for the administration of Postinor-2 tablet. In case of vaginal bleeding of unknown origin, hepatic and biliary disease, history of gestational jaundice, breast, ovarian or uterine carcinoma, it should be administered after careful consideration of the risk/benefit ratio (unwanted pregnancy/abortion).

DOSAGE
One Postinor-2 tablet should be ingested within 72 hours following intercourse and another one 12 hours after taking the first tablet.
According to data of clinical studies, it is advisable to take the first tablet within 48 hours (but not later than 72 hours) after intercourse, since the efficacy of the preparation decreases if more than 48 hours elapse between intercourse and drug ingestion. Postinor-2 tablet may be used at any time within the menstrual cycle.

 

If vomiting occurs within 2 hours after drug intake, the dose must be repeated.


SIDE EFFECTS
Nausea: it occurs in approximately 25% of users.


Vomiting: in 5%


Bleeding disturbances: in some cases, 2-3 days following tablet ingestion breakthrough or withdrawal bleeding may occur that generally ceases spontaneously. In the majority of cases the next period starts as expected or somewhat earlier. If the period is more than 7 days late it is recommended to perform a pregnancy test.


In case of prolonged or heavy bleeding, gynaecological examination is advised.

 

Other side-effects: breast tenderness, headache, dizziness, fatigue.

DRUG INTERACTIONS
Concomitant use of ampicillin, rifampicin, chloramphenicol, neomycin, sulphonamides, tetracyclines, barbiturates and phenylbutazone may reduce the contraceptive effect.

WARNING
Use with utmost care in case of asthma, heart failure, hypertension, migraine, epilepsy, renal impairment, diabetes mellitus, hyperlipidaemia, depression and in case of existing or former thrombophlebitis, thromboembolic diseases or stroke.


The preparation may be used exclusively in the above mentioned emergency cases; it is not appropriate for regular use.

STORAGE
Protected from humidity, at a temperature between 15-30C.

PACKAGE
2 tablets in a blister. 1 blister in an inner carton. 5 inner carton in a box.

Abdomen
Blood
Bone
Breast
Ear

Eye

Face
Hair

Head

Heart
Kidney
Liver
Limbs
Lungs
newMind
Mouth
Muscles
Nails

Neck

newNerves
Nose

Skin

Teeth

Throat

Tongue
 
Health news
 
Cardiovascular Guide
 
Natural Remedies
 
Treatment of Cancer
 
Women's Health
 
Irritable bowel syndrome
 
Common Childhood Illnesses
 
Prescribed Drugs
 
 

     
         
     

 

Disclaimer